Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

NCT05042258 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis
Sleep Disturbance

Interventions

DRUG: Dupilumab

Sponsor

Northwestern University

Collaborators

[object Object]